Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes
Titel:
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes
Auteur:
Tavares, G. Marques, D. Barra, C. Rosendo-Silva, D. Costa, A. Rodrigues, T. Gasparini, P. Melo, B.F. Sacramento, J.F. Seiça, R. Conde, S.V. Matafome, P.